# Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment

> **NCT06679920** · NA · RECRUITING · sponsor: **Amsterdam UMC** · enrollment: 15 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **DEVICE:** Optical coherence tomography

## Key facts

- **NCT ID:** NCT06679920
- **Lead sponsor:** Amsterdam UMC
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12
- **Primary completion:** 2025-03
- **Final completion:** 2025-04
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2024-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06679920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06679920, "Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT06679920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*